🌎 Dycom Industries Initiated, Zillow Group Initiated, Banner Upgraded and more…
RJ Hamster
Advertisements
Ratings changes for Lexicon Pharmaceuticals, bluebird bio, Aethlon Medical, BIOLASE, Edap Tms, Galmed Pharmaceuticals, Sotherly Hotels and more…Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
Last Chance to Invest in the Agentic AI Startup Disrupting the $5.7T Hospitality Industry — Jurny’s Round Almost Full! (ad)
The real estate economy is under pressure. Margins are tight, labor is costly, and short-term rentals and hotels are increasingly difficult to scale — all while guest expectations continue to rise. Today’s travelers demand 5-star hotel-quality service, instant support, and seamless digital experiences.
Amazon.com (NASDAQ:AMZN) had its “outperform” rating reaffirmed by Raymond James () (analyst Josh Beck). They now have a $195.00 price target on the stock, down previously from $275.00. This represents a 16.4% upside from the current price of $167.53.
CEO Sundar Pichai sold 32,500 shares of the business’s stock in a transaction on Wednesday, April 16th. The stock was sold at an average price of $156.16, for a total transaction of $5,075,200.00. Following the sale, the chief executive officer now owns 2,685,196 shares in the company, valued at $419,320,207.36. The trade was a 1.20 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Banner (NASDAQ:BANR) was upgraded by analysts at Janney Montgomery Scott from a “neutral” rating to a “buy” rating. They now have a $71.00 price target on the stock. This represents a 18.5% upside from the current price of $59.93.
Centerspace (NYSE:CSR) was upgraded by analysts at Raymond James from a “market perform” rating to an “outperform” rating. They now have a $66.00 price target on the stock. This represents a 11.9% upside from the current price of $58.97.
Walt Disney (NYSE:DIS) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating. They now have a $112.00 price target on the stock. This represents a 34.4% upside from the current price of $83.32.
Chesapeake Energy (NASDAQ:EXE) was upgraded by analysts at KeyCorp from a “sector weight” rating to an “overweight” rating. They now have a $130.00 price target on the stock. This represents a 24.4% upside from the current price of $104.47.
Fidelity National Information Services (NYSE:FIS) was upgraded by analysts at TD Cowen from a “hold” rating to a “buy” rating. They now have a $92.00 price target on the stock. This represents a 18.2% upside from the current price of $77.84.
Fidelity National Information Services (NYSE:FIS) was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating. They now have a $86.00 price target on the stock, up previously from $79.00. This represents a 10.5% upside from the current price of $77.84.
F.N.B. (NYSE:FNB) was upgraded by analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating. They now have a $16.50 price target on the stock. This represents a 32.2% upside from the current price of $12.48.
Imperial Oil (NYSEAMERICAN:IMO) (TSE:IMO) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating.The current price is $64.31.
Norwegian Cruise Line (NYSE:NCLH) was upgraded by analysts at Loop Capital from a “hold” rating to a “buy” rating. They now have a $25.00 price target on the stock. This represents a 54.3% upside from the current price of $16.21.
Intellia Therapeutics (NASDAQ:NTLA) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating. They now have a $21.00 price target on the stock. This represents a 169.2% upside from the current price of $7.80.
Spotify Technology (NYSE:SPOT) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating. They now have a $660.00 price target on the stock. This represents a 15.6% upside from the current price of $570.94.
BBB Foods (NYSE:TBBB) was upgraded by analysts at Itau BBA Securities from a “market perform” rating to an “outperform” rating. They now have a $36.00 price target on the stock. This represents a 39.1% upside from the current price of $25.88.
United Therapeutics (NASDAQ:UTHR) was upgraded by analysts at Bank of America Co. from an “underperform” rating to a “neutral” rating. They now have a $314.00 price target on the stock. This represents a 9.2% upside from the current price of $287.64.
Wolverine World Wide (NYSE:WWW) was upgraded by analysts at Robert W. Baird from a “neutral” rating to an “outperform” rating. They now have a $15.00 price target on the stock. This represents a 30.8% upside from the current price of $11.47.
While other cell phone carriers are always looking for ways to squeeze every last penny out of their customers, my company pays users for the 40 hours a week they are using smartphone apps, listening to music, and watching videos online with their phones.
And you can join us for just $0.26 per share. Plus, when you invest now, you can get up to 100% bonus shares!
Canadian Imperial Bank of Commerce (NYSE:CM) (TSE:CM) was downgraded by analysts at Jefferies Financial Group Inc. from a “buy” rating to a “hold” rating.The current price is $58.45.
Global Payments (NYSE:GPN) was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating. They now have a $78.00 price target on the stock. This represents a 15.9% upside from the current price of $67.29.
Infosys (NYSE:INFY) was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “neutral” rating. They now have a $17.90 price target on the stock. This represents a 8.6% upside from the current price of $16.48.
Prologis (NYSE:PLD) was downgraded by analysts at Wolfe Research from an “outperform” rating to a “peer perform” rating.The current price is $99.40.
UnitedHealth Group (NYSE:UNH) was downgraded by analysts at Argus from a “buy” rating to a “hold” rating.The current price is $435.12.
Abercrombie & Fitch (NYSE:ANF) is now covered by analysts at Barclays PLC. They set an “equal weight” rating and a $71.00 price target on the stock. This represents a 0.4% upside from the current price of $70.70.
Context Therapeutics (NASDAQ:CNTX) is now covered by analysts at William Blair. They set an “outperform” rating on the stock.The current price is $0.84.
Dycom Industries (NYSE:DY) is now covered by analysts at JPMorgan Chase & Co.. They set an “overweight” rating and a $200.00 price target on the stock. This represents a 29.7% upside from the current price of $154.24.
Genius Sports (NYSE:GENI) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $12.00 price target on the stock. This represents a 18.3% upside from the current price of $10.14.
Grail (NASDAQ:GRAL) is now covered by analysts at Canaccord Genuity Group Inc.. They set a “buy” rating and a $32.00 price target on the stock. This represents a 21.3% upside from the current price of $26.38.
Hut 8 (NASDAQ:HUT) is now covered by analysts at Northland Securities. They set an “outperform” rating and a $20.00 price target on the stock. This represents a 82.3% upside from the current price of $10.97.
STAAR Surgical (NASDAQ:STAA) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $17.00 price target on the stock. This represents a 4.3% upside from the current price of $16.30.
Tectonic Therapeutic (NASDAQ:TECX) is now covered by analysts at Mizuho. They set an “outperform” rating and a $51.00 price target on the stock. This represents a 200.9% upside from the current price of $16.95.
Tempus AI (NASDAQ:TEM) is now covered by analysts at BTIG Research. They set a “buy” rating and a $60.00 price target on the stock. This represents a 50.3% upside from the current price of $39.92.
Unicycive Therapeutics (NASDAQ:UNCY) is now covered by analysts at Guggenheim. They set a “buy” rating and a $6.00 price target on the stock. This represents a 861.5% upside from the current price of $0.62.
Verona Pharma (NASDAQ:VRNA) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $80.00 price target on the stock. This represents a 34.2% upside from the current price of $59.62.
Xencor (NASDAQ:XNCR) is now covered by analysts at William Blair. They set an “outperform” rating on the stock.The current price is $9.82.
Zillow Group (NASDAQ:Z) is now covered by analysts at William Blair. They set a “market perform” rating on the stock.The current price is $61.76.
Zillow Group (NASDAQ:ZG) is now covered by analysts at William Blair. They set a “market perform” rating on the stock.The current price is $60.64.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
